Chemoembolization and percutaneous ethanol injection for intrahepatic recurrence of hepatocellular carcinoma after hepatic resection

Hepato-Gastroenterology

Volumn 43, Issue 12, 1996, Pages 1421-1426

  Sato, M ^a   Watanabe, Y ^a   Iseki, N ^a   Ueda, S ^a   Kawach, K ^a   Kimura, S ^a   Itoh, Y ^a   Ohkubo, K ^a   Onji, M ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoembolization; Hepatic resection; Hepatocellular carcinoma; Percutaneous ethanol injection; Recurrence

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; IODINATED POPPYSEED OIL; MITOMYCIN C;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PATIENT CARE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CONTRAST MEDIA; DRUG CARRIERS; ETHANOL; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, INTRALESIONAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 0030475572     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, Yamasaki S. Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepato-Gastroenterol. 1993; 40: 328-332.
2. Nagasue N, Yukaya H, Chang YC, Yamanoi A, Kohno H, Hayashi T, Nakamura T. Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma. Surg. Gynecol. Obstet. 1990; 171: 217-222.
3. Tanikawa K, Majima Y. Percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma. Hepato-Gastroenterol. 1993; 40: 324-327.
4. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumida H, Watanabe G, Tsurumaru M. Risk factors for tumor recurrence and prognosis after resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
5. Takayasu K, Wakao F, Moriyama N, Muramatsu Y, Yamazaki S, Kosuge T, Takayama T, Okada S, Okazaki N, Makuuchi M.: Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1992; 16: 906-911.
6. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, Roche A. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Amer. J. Surg. 1992; 163: 387-394.
7. Kanematsu T, Matsumata T, Furuta T, Shirabe K, Yamagata M, Utsunomiya T, Sugimachi K. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma. Hepato-Gastroenterol. 1990; 37: 442-444.
8. Furuta T, Kanematsu T, Matsumata T, Shirabe K, Yamagata M, Utsunomiya T, Sugimachi K. Lipiodolization prolongs survival rates in postoperative patients with a recurrent hepatocellular carcinoma. Hepato-Gastroenterol. 1990; 37: 494-497.
9. Bhattacharya S, Novell JR, Winslet MC, Hobbs KEF. Iodized oil in the treatment of hepatocellular carcinoma. Br. J. Surg. 1994; 81: 1563-1571.
10. Izumi R, Shimizu K, Iyobe T, Ii T, Yagi M, Matsui O, Nonomura A, Miyazaki I. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20: 295-301.
11. Tanaka K, Okazaki H, Nahamura S, Endo O, Inoue S, Takamura Y, Sugiyama M, Ohaki Y. Hepatocellular carcinoma: Treatment with a combination therapy of transcathter arterial embolization and percutaneous ethanol injection. Radiology 1991; 179: 713-717.
12. Suenaga M, Sugiura H, Kokuba Y, Uehara S, Kurumiya T. Repeated hepatic resection for recurrent hepatocellular carcinoma in eighteen cases. Surgery 1994; 115: 452-457.
13. Couinaud C. Etudes Anatomiques et Chirugicales. Paris: Masson Publisher, 1957
14. Healey JE Jr, Shroy PC. Anatomy of the biliary ducts within the human liver. Arch. Surg. 1953; 66: 599-616.
15. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 cases necropsies. Cancer 1954; 7: 462-503.
16. Takayasu K, Moriyama N, Muramatsu Y, Makuuchi M, Hasegawa H, Okazaki N, Hirohashi S. The diagnosis of small hepatocellular carcinoma: efficacy of various imaging procedures in 100 patients. A.J.R. 1990; 155: 49-54.
17. Tsuda H, Odd T, Sakamoto M, Hirohashi S. Cancer Res. 1992; 52: 1504-1509.
18. Nonami T, Isshiki K, Katoh H, Kishimoto W, Harada A, Nakao A, Takagi H. The potential role of postoperative hepatic artery chemotherapy in patients with high-risk hepatomas. Ann. Surg. 1991; 213: 222-226.
19. Sato M, Watanabe Y, Lee T, Kito K, Kimura S, Itoh Y, Akamatsu K, Ueda N. Well-differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection. Amer. J. Gastroenterol. 1995; 90: 112-116.
20. Hsu HC, Wei TC, Tsang YM, Wu MZ, Lin YH, Chuang SM. Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer 1986; 57: 1184-1191.